Combinations of cytokines promote survival of mice and limit acute radiation damage in concert with amelioration of vascular damage

Radiation Research

Volumn 161, Issue 5, 2004, Pages 549-559

  Van Der Meeren, Anne ^a,b   Mouthon, Marc André ^a   Vandamme, Marie ^a   Squiban, Claire ^a   Aigueperse, Jocelyne ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^b CEA DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CHEMOKINE; CYTOKINE; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 11; INTERLEUKIN 4; MESSENGER RNA; PLACEBO; PROTEIN; THROMBOPOIETIN; ALPHA CHEMOKINE; CXCL1 PROTEIN, MOUSE; KERATINOCYTE DERIVED CHEMOKINES; KERATINOCYTE-DERIVED CHEMOKINES;

ANIMAL EXPERIMENT; ANIMAL MODEL; APLASIA; ARTICLE; BLOOD VESSEL INJURY; BLOOD VESSEL PERMEABILITY; CAPILLARY LEAK SYNDROME; HEMATOPOIESIS; INFLAMMATION; LUNG; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION INJURY; SURVIVAL RATE; TISSUE INJURY; WHOLE BODY RADIATION; ACUTE DISEASE; ANIMAL; BLOOD; C57BL MOUSE; COMPARATIVE STUDY; DRUG COMBINATION; DRUG POTENTIATION; MALE; PATHOLOGY; TREATMENT OUTCOME; VASCULAR DISEASE;

ACUTE DISEASE; ANIMALS; CHEMOKINES; CHEMOKINES, CXC; CYTOKINES; DRUG COMBINATIONS; DRUG SYNERGISM; INTERLEUKIN-11; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; RADIATION INJURIES; SURVIVAL RATE; THROMBOPOIETIN; TREATMENT OUTCOME; VASCULAR DISEASES; WHOLE-BODY IRRADIATION;

EID: 3042848993     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3164     Document Type: Article

References (68)

1. A. M. Farese, D. E. Williams, F. R. Seiler and T. J. MacVittie, Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia. Blood 82, 3012-3018 (1993).
2. K. J. Neelis, Y. D. Dubbelman, L. Qingliang, G. R. Thomas, D. L. Eaton and G. Wagemaker, Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells. Exp. Hematol. 25, 1084-1093 (1997).
3. M. A. Mouthon, A. Van der Meeren, M. H. Gaugler, T. P. Visser, C. Squiban, P. Gourmelon and G. Wagemaker, Thrombopoietin promotes hematopoietic recovery and survival after high-dose whole body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 43, 867-875 (1999).
4. F. Herodin, P. Bourin, J. F. Mayol, J. J. Lataillade and M. Drouet, Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma-irradiation promotes survival. Blood 101, 2609-2616 (2003).
5. B. M. Curtis, D. E. Williams, H. E. Broxmeyer, J. Dunn, T. Farrah, E. Jeffery, W. Clevenger, P. deRoos, U. Martin and D. Friend, Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc. Natl. Acad. Sci. USA 88, 5809-5813 (1991).
6. A. M. Farese, W. G. Smith, J. G. Giri, N. Siegel, J. P. McKearn and T. J. MacVittie, Promegapoietin-1a, an engineered chimeric IL-3 and Mpl-L receptor agonist, stimulates hematopoietic recovery in conventional and abbreviated schedules following radiation-induced myelosuppression in nonhuman primates. Stem Cells 19, 329-338 (2001).
7. M. A. Mouthon, M. H. Gaugler, M. Vandamme, P. Gourmelon, G. Wagemaker and A. Van der Meeren, Ticlopidine inhibits the prothrombotic effects of thrombopoietin and ameliorates survival after supralethal total body irradiation. Thromb. Haemost. 87, 323-328 (2002).
8. C. L. Farrell, K. L. Rex, S. A. Kaufman, C. R. Dipalma, J. N. Chen, S. Scully and D. L. Lacey, Effects of keratinocyte growth factor in the squamous epithelium of the upper aerodigestive tract of normal and irradiated mice. Int. J. Radiat. Biol. 75, 609-620 (1999).
9. P. Okunieff, M. Mester, J. Wang, T. Maddox, X. Gong, D. Tang, M. Coffee and I. Ding, In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat. Res. 150, 204-211 (1998).
10. A. S. Michalowski, On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs. Acta Oncol. 33, 139-157 (1994).
11. A. Molteni, J. E. Moulder, E. F. Cohen, W. F. Ward, B. L. Fish, J. M. Taylor, L. F. Wolfe, L. Brizio-Molteni and P. Veno, Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int. J. Radiat. Biol. 76, 523-532 (2000).
12. L. W. Wang, X. L. Fu, R. Clough, G. Sibley, M. Fan, G. C. Bentel, L. B. Marks and M. S. Anscher, Can angiotensin-converting enzyme inhibitors protect against symptomatic radiation pneumonitis? Radiat. Res. 153, 405-410 (2000).
13. F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo and R. Kolesnick, Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293-297 (2001).
14. F. A. Stewart, J. A. Te Poele, A. F. Van der Wal, Y. G. Oussoren, E. M. Van Kleef, A. Kuin, M. Verheij and L. G. Dewit, Radiation nephropathy - the link between functional damage and vascular mediated inflammatory and thrombotic changes. Acta Oncol. 40, 952-957 (2001).
15. J. W. Hopewell, The role of endothelial cells in the radiation response of critical organ systems. Br. J. Radiol. 26 (Suppl.), 220-225 (2002).
16. W. C. Aird, The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101, 3765-3777 (2003).
17. A. Van der Meeren, M-H. Gaugler, M-A. Mouthon, C. Squiban and P. Gourmelon, Il4 promotes survival of lethally irradiated mice in the absence of hematopoietic recovery. Radiat. Res. 152, 629-636 (1999).
18. A. Van der Meeren, M. A. Mouthon, M. H. Gaugler, M. Vandamme and P. Gourmelon, Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: Interactive effect with thrombopoietin. Radiat. Res. 157, 642-649 (2002).
19. A. Van der Meeren, C. Squiban, P. Gourmelon, H. Lafont and M-H. Gaugler, Differential regulation by IL-4 and IL-10 of radiation-induced IL-6 and IL-8 production and ICAM-1 expression by human endothelial cells. Cytokine 11, 831-838 (1999).
20. A. Van der Meeren, P. Monti, L. Lebaron-Jacobs, C. Marquette and P. Gourmelon, Characterization of the acute inflammatory response after irradiation in mice and its regulation by interleukin-4. Radiat. Res. 155, 858-865 (2001).
21. C. Potten, Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin-11 also increases murine survival time. Stem Cells 14, 452-459 (1996).
22. A. Orazi, X. X. Du, Z. Yang, M. Kashai and D. Williams, Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab. Invest. 75, 33-42 (1996).
23. C. A. Redlich, X. Gao, S. Rockwell, M. Kelley and J. A. Elias, IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J. Immunol. 157, 1705-1710 (1996).
24. S. T. Sonis, R. L. Paterson, L. J. Edwards, C. A. Lucey, L. Wang, L. Mason, G. Login, M. Ymamkawa, G. Moses and A. J. Dorner, Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 36, 373-381 (2000).
25. D. Frasca, F. Guidi, M. Arbitrio, C. Pioli, F. Poccia, R. Cicconi and G. Doria, Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: Effects of different hematopoietic cytokines on the recovery of the thymus, spleen and blood cells. Bone Marrow Transplant. 25, 427-433 (2000).
26. D. Frasca, C. Pioli, F. Guidi, S. Pucci, M. Arbitrio, G. Leter and G. Doria, IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation. Int. Immunol. 8, 1651-1657 (1996).
27. R. A. Nash, K. Seidel, R. Storb, S. Slichter, F. G. Schuening, F. R. Appelbaum, A. B. Becker, L. Bolles, H. J. Deeg and S. A. Burstein, Effects of rhIL-11 on normal dogs after sublethal irradiation. Exp. Hematol. 23, 389-396 (1995).
28. K. Mahboubi, F. Li, J. Plescia, N. C. Kirkiles-Smith, M. Mesri, Y. Du, J. M. Carroll, J. A. Elias, D. C. Altieri and J. S. Pober, Interleukin-11 up-regulates surviving expression in endothelial cells through a signal transducer and activator of transcription-3 pathway. Lab. Invest. 81, 327-334 (2001).
29. M. Garcia-Barros, F. Paris, C. Cordon-Cardo, D. Lyden, S. Rafii, A. Haimovitz-Friedman, Z. Fuks and R. Kolesnick, Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159 (2003).
30. X. Du, Q. Liu, Z. Yang, A. Orazi, F. J. Rescorla, J. L. Grosfeld and D. A. Williams, Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. Am. J. Physiol. 272, G545-552 (1997).
31. J. C. Keith, Jr., L. Albert, S. T. Sonis, C. J. Pfeiffer and R. G. Schaub, IL-11, a pleiotropic cytokine: Exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 12, 79-89 (1994).
32. A. B. Waxman, O. Einarsson, T. Seres, R. G. Knickelbein, J. B. Warshaw, R. Johnston, R. J. Homer and J. A. Elias, Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J. Clin. Invest. 101, 1970-1982 (1998).
33. M. A. Mouthon, M. H. Gaugler, A. Van der Meeren, M. Vandamme, P. Gourmelon and G. Wagemaker, Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality. Exp. Hematol. 29, 30-40 (2001).
34. M. A. Mouthon, A. Van der Meeren, M. Vandamme, C. Squiban, M. H. Gaugler and P. Gourmelon, Thrombopoietin protects mice from mortality and myelosuppression following high-dose irradiation: Importance of time scheduling. Can. J. Physiol. Pharmacol. 80, 717-721 (2002).
35. K. J. Neelis, L. Qingliang, G. R. Thomas, B. L. Cohen, D. L. Eaton and G. Wagemaker, Prevention of thrombocytopenia by thrombopoietin in myelosuppressed rhesus monkeys accompanied by prominent erythropoietic stimulation and iron depletion. Blood 90, 58-63 (1997).
36. K. J. Neelis, T. P. Visser, W. Dimjati, G. R. Thomas, P. J. Fielder, D. Bloedow, D. L. Eaton and G. Wagemaker, A single dose of thrombopoietin early after myelosuppressive total body irradiation prevents pancytopenia by promoting short-term multilineage repopulating cells at the expense of a more immature cell population. Blood 92, 1586-1597 (1998).
37. J. E. Moulder, Multiorgan problems associated with total or partial body irradiation. In The Medical Basis for Radiation Accident Preparedness (M. E. Berger, F. M. O'Hara, Jr. and R. C. Ricks, Eds.), pp. 175-190. Parthenon Publishing, Boca Raton, FL, 2001.
38. T. Ishii, S. Futami, M. Nishida, T. Suzuki, T. Sakamoto, N. Suzuki and K. Maekawa, Brief note and evaluation of acute-radiation syndrome and treatment of a Tokai-mura criticality accident patient. J. Radiat. Res. 42 (Suppl.), S167-S182 (2001).
39. C. H. Ts'ao, W. F. Ward and C. D. Port, Radiation injury in rat lung. I. Prostacyclin (PGI2) production, arterial perfusion, and ultrastructure. Radiat. Res. 96, 284-293 (1983).
40. J. Hong, C. Chiang, C. Tsao, P. Lin, W. McBride and C. Wu, Rapid induction of cytokine gene expression in the lung after single and fractionated doses of irradiation. Int. J. Radiat. Biol. 75, 14121-11427 (1999).
41. D. Hallahan, E. Talley Clark, J. Kuchibhotla, B. L. Gewertz and T. Collins, E-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochem. Biophys. Res. Commun. 217, 784-795 (1995).
42. D. E. Hallahan and S. Virudachalam, Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Res. 57, 2096-2099 (1997).
43. D. E. Hallahan and S. Virudachalam, Accumulation of P-selectin in the lumen of irradiated blood vessels. Radiat. Res. 152, 6-13 (1999).
44. J. R. Maisin, The ultrastructure of the lung of mice exposed to a supra-lethal dose of ionizing radiation on the thorax. Radiat. Res. 44, 545-564 (1970).
45. R. A. Rosiello, W. W. Merrill, S. Rockwell, D. Carter, J. A. Cooper, Jr., S. Care and E. P. Amento, Radiation pneumonitis. Bronchoalveolar lavage assessment and modulation by a recombinant cytokine. Am. Rev. Respir. Dis. 148, 1671-1676 (1993).
46. P. Rubin, C. J. Johnston, J. P. Williams, S. McDonald and J. N. Finkelstein, A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33, 99-109 (1995).
47. C. J. Johnston, B. Piedboeuf, P. Rubin, J. P. Williams, R. Baggs and J. N. Finkelstein, Early and persistent alterations in the expression of interleukin-1α, interleukin-1β and tumor necrosis factor α mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat. Res. 145, 762-767 (1996).
48. A. Van der Meeren, M. Vandamme, C. Squiban, M. H. Gaugler and M. A. Mouthon, Inflammatory reaction and changes in expression of coagulation proteins on lung endothelial cells after total-body irradiation in mice. Radiat. Res. 160, 637-646 (2003).
49. L. Huang, F. Ogushi, K. Tani, H. Ogawa, T. Kawano, T. Endo, K. Izumi, N. Sono, J. Ueno and S. Sone, Thrombin promotes fibroblast proliferation during the early stages of experimental radiation pneumonitis. Radiat. Res. 156, 45-52 (2001).
50. I. Brook and G. D. Ledney, Quinolone therapy in the management of infection after irradiation. Crit. Rev. Microbiol. 18, 235-246 (1992).
51. C. M. Leutenegger, C. N. Mislin, B. Sigrist, M. U. Ehrengruber, R. Hofmann-Lehmann and H. Lutz, Quantitative real-time PCR for the measurement of feline cytokine mRNA. Vet. Immunol. Immunopathol. 71, 291-305 (1999).
52. J. Panès, D. C. Anderson, M. Miyasaka and D. N. Granger, Role of leukocyte-endothelial cell adhesion in radiation-induced microvascular dysfunction in rats. Gastroenterology 108, 1761-1769 (1995).
53. S. Quarmby, P. Kumar and S. Kumar, Radiation-induced normal tissue injury: Role of adhesion molecules in leukocyte-endothelial cell interactions. Int. J. Cancer 82, 385-395 (1999).
54. J. Panes and D. N. Granger, Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114, 1066-1090 (1998).
55. V. Vereycken-Holler, J. Aigueperse and M. H. Gaugler, Radiation effects on circulating and endothelial cell interactions studied by quantitative real-time videomicroscopy. Int. J. Radiat. Biol. 78, 923-930 (2002).
56. M. A. Mouthon, V. Vereycken-Holler, A. Van der Meeren and M. H. Gaugler, Irradiation increases the interactions of platelets with the endothelium in vivo: Analysis by intravital microscopy. Radiat. Res. 160, 593-599 (2003).
57. Q. Zhou, Y. Zhao, X. Bai and C. Ruan, Thrombomodulin as a marker of radiation-induced endothelial cell injury. Radiat. Res. 131, 285-289 (1992).
58. K. K. Richter, L. M. Fink, B. M. Hughes, C. C. Sung and M. Hauer-Jensen, Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother. Oncol. 44, 65-71 (1997).
59. J. Wang, H. Zheng, X. Ou, L. M. Fink and M. Hauer-Jensen, Deficiency of microvascular thrombomodulin and up-regulation of protease-activated receptor-1 in irradiated rat intestine: Possible link between endothelial dysfunction and chronic radiation fibrosis. Am. J. Pathol. 160, 2063-2072 (2002).
60. E. van Kleef, M. Verheij, H. te Poele, Y. Oussoren, L. Dewit and F. Stewart, In vitro and in vivo expression of endothelial von Willebrand factor and leukocyte accumulation after fractionated irradiation. Radiat. Res. 154, 375-381 (2000).
61. D. E. Hallahan, L. Geng, S. Qu, C. Scarfone, T. Giorgio, E. Donnely, X. Gao and J. Clanton, Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 3, 63-74 (2003).
62. D. G. Baker and R. J. Krochak, The response of the microvascular system to radiation: A review. Cancer Invest. 7, 287-294 (1989).
63. M. P. Law, Radiation-induced vascular injury and its relation to late effects in normal tissues. Adv. Radiat. Biol. 9, 38-71 (1981).
64. J. E. Cardier and J. Dempsey, Thrombopoietin and its receptor, c-mpl, are constitutively expressed by mouse liver endothelial cells: Evidence of thrombopoietin as a growth factor for liver endothelial cells. Blood 91, 923-929 (1998).
65. M. F. Brizzi, E. Battaglia, G. Montrucchio, P. Dentelli, L. Del Sorbo, G. Garbarino, L. Pegoraro and G. Camussi, Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ. Res. 84, 785-796 (1999).
66. J. E. Cardier, Effects of megakaryocyte growth and development factor (thrombopoietin) on liver endothelial cells in vitro. Microvasc. Res. 58, 108-113 (1999).
67. C. Cicala and G. Cirino, Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk. Life Sci. 62, 1817-1824 (1998).
68. P. Libby and D. I. Simon, Inflammation and thrombosis: the clot thickens. Circulation 103, 1718-1720 (2001).